Patent US4433060A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4433060A Expired / Lapsed US ⏱️ 0.0 years remaining

Chemiluminescent immunoassays with triphenylmethane dyes activated by H.sub. O2 and a chloramine

Assignee: Individual
•
Filing: 1981-05-26
•
Granted: 1984-02-21
•
Expires: 2001-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Process for the quantitative and qualitative determination of antigens, antibodies and their complexes by means of a chemiluminescing labelling substance activated or excited to chemiluminescence by an analytical reagent. By means of a serological reaction, initially an antigen/antibody complex is formed which is treated with a chemiluminescing conjugate containing chemiluminescing triphenylmethane dyes and the chemiluminescence of the chemiluminescing complex formed is measured. Qualitative or quantitative details on the substances to be measured are obtained on the basis of the resulting measured values. The dye labels are activated by either hypochlorites or mixtures of H 2 O 2 and a chloramine.

Inventors

  • 👤 Bernd Frenzel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 17:49
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/582; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/82

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 139 words
A process for the quantitative or qualitative determination of antigens, antibodies, and their complexes by means of a chemiluminescing labelling substance excited or activated for chemiluminescence by an analytical reagent, which comprises the steps of: (a) forming a chemiluminescing complex by (i) forming an antigen/antibody complex by means of a serological reaction; treating said antigen/antibody complex with a chemiluminescing conjugate containing a chemiluminescing labelling substance in the form of a chemiluminescing triphenylmethane dye coupled to an antigen, antibody or antigen/antibody complex to give said chemiluminescing complex; or (ii) directly forming said chemiluminescing complex by means of a serological reaction between said chemiluminescing conjugate and an antigen or antibody; (b) separating said chemiluminescing complex; (c) adding an exciting analytical reagent selected from mixtures of H 2 O 2 with a chloramine; and (d) measuring the chemiluminescence resulting from step (c).
Claim 2
Dependent Claim 139 words
A process for the quantitative or qualitative determination of antigens, antibodies, and their complexes by means of a chemiluminescing labelling substance excited or activated for chemiluminescence by an analytical reagent, which comprises the steps of: (a) forming a chemiluminescing complex by (i) forming an antigen/antibody complex by means of a serological reaction; treating said antigen/antibody complex with a chemiluminescing conjugate containing a chemiluminescing labelling substance in the form of a chemiluminescing triphenylmethane dye coupled to an antigen, antibody or antigen/antibody complex to give said chemiluminescing complex; or (ii) directly forming said chemiluminescing complex by means of a serological reaction between said chemiluminescing conjugate and an antigen or antibody; (b) separating said chemiluminescing complex; (c) adding an exciting analytical reagent selected from mixtures of H 2 O 2 with a chloramine; and (d) measuring the chemiluminescence resulting from step (c).
Claim 3
Dependent Claim 13 words
A process according to claim 1, wherein a solid phase assay is used.
Claim 4
Dependent Claim 15 words
A process according to claim 1, wherein the chemiluminescence is measured in an aqueous medium.
Claim 5
Dependent Claim 16 words
A process according to claim 1, wherein the chemiluminescence measurement is performed in a basic medium.
Claim 6
Dependent Claim 19 words
A process according to claim 1, wherein fluorescein isothiocyanate or fluorescein isocyanate is used as the chemiluminescing labelling substance.
Claim 7
Dependent Claim 13 words
A process according to claim 1, wherein a hepatitis B antigen is identified.
Claim 8
Dependent Claim 14 words
A process according to claim 1 or 2, wherein a sandwich assay is used.

References Cited (Backward Citations)

US4104029A Cited
US4238195A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-02-20 1987-08-22 1988-02-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-02-20 1991-08-22 1992-02-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-02-20 1995-08-22 1996-02-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag